Trial Condition(s):
Multiple Sclerosis, Relapsing-Remitting
Impact of the BETACONNECT auto-injector on BETASERON therapy adherence and patient satisfaction
Bayer Identifier:
17942
ClinicalTrials.gov Identifier:
EudraCT Number:
Not Available
EU CT Number:
Not Available
Trial Purpose
The primary objective of this study is to assess adherence and persistence to BETASERON therapy in patients who are using the BETACONNECT auto-injector device (BETACONNECT device).
The secondary objective of this study is to assess patient-reported satisfaction with the BETACONNECT device.
Inclusion Criteria
- Male and females greater than or equal to 18 years of age - Diagnosis of RRMS according to revised McDonald Criteria (2010) or (CIS) - Prescribed BETASERON (note: decision to treat with BETASERON must be made independent of participation in this study) - Confirmation of insurance coverage for BETASERON treatment - Access to a personal computer to complete online patient satisfaction survey at Week 6
Exclusion Criteria
- Currently enrolled in a clinical trial or other observational study for Multiple Sclerosis treatment - Documented substance abuse within the previous 6 months prior to study enrollment - Any major laboratory value abnormality that the investigator believes would preclude the patient from participating in the study - Any medical disorder, condition or history that in the opinion of the investigator would impair the patient’s ability to participate in or complete the study - Pregnant or nursing
Trial Summary
Enrollment Goal
Trial Dates
Phase
Could I receive a placebo?
Products
Accepts Healthy Volunteers
Where to Participate
| Locations | |
|---|---|
Locations Investigative Site Lubbock, United States, 79430 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Stratford, United States, 08084 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Deckerville, United States, 48427 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Memphis, United States, 38104 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Tampa, United States, 33609 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Boca Raton, United States, 33428 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Teaneck, United States, 07666 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Round Rock, United States, 78681 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Fulton, United States, 20759 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Franklin, United States, 37064 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Cullman, United States, 35058 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Lititz, United States, 17543 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Nashville, United States, 37212 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Foxboro, United States, 02035 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Staten Island, United States, 10306 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site New Port Richey, United States, 34653 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Fairfax, United States, 22031 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site St. Louis, United States, 63131 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Bala Cynwyd, United States, 19004 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Atlanta, United States, 30309-1465 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Medford, United States, 97504 | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Virginia Beach, United States | Contact Us: E-mail: [email protected] Phone: Not Available |
Locations Investigative Site Medford, United States | Contact Us: E-mail: [email protected] Phone: Not Available |
Trial Design
Impact of the BETACONNECT auto-injector on BETASERON therapy adherence and patient satisfaction
Trial Type:
Observational
Intervention Type:
Drug
Trial Purpose:
N/A
Allocation:
N/A
Blinding:
N/A
Assignment:
N/A
Trial Arms:
1
Primary Outcome
- Number of BETASERON injections as captured by the BETACONNECT deviceTimeframe: At 6 months
- Time (days) between BETASERON injections as captured by BETACONNECT deviceTimeframe: At 6 months
Secondary Outcome
- Patient reported satisfaction by a questionnaireTimeframe: At 6 weeks
Additional Information
Copyright © Bayer
Powered by
